MedPath

Effects of Whole Body Vibration on Autonomic Function in Healthy Young and Elderly

Not Applicable
Completed
Conditions
Healthy
Aging
Interventions
Other: Whole Body Vibration
Registration Number
NCT03180814
Lead Sponsor
Universidade Federal de Pernambuco
Brief Summary

Aging causes anatomical and physiological changes in the cardiovascular system and autonomic function with decline in its maximum function. This study aimed to evaluate the acute effects of whole body vibration on cardiovascular system, autonomic function and heart variability in healthy young and elderly. The investigators' hypothesis is that whole body vibration has different effects in young and elderly.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • Elderly individuals aged between 60 and 80 years
  • Young individuals aged between 18 and 30 years
  • Able to walk without assistance
  • Good understanding to perform the proposed procedures
  • Sedentary or low active
Exclusion Criteria
  • Body Mass Index (BMI) > 35Kg/m2
  • Systolic blood pressure > 140 mmHg or diastolic blood pressure > 90 mmHg (at rest)
  • Difficulty adapting to the whole body vibration
  • Smoking
  • Neuromuscular or degenerative disorders
  • Neurological diseases
  • Cardiopulmonary comorbidities
  • Cardiac arrhythmias
  • Osteoarticular disorders
  • Use of hormone replacement therapy
  • Use medications or supplements known to affect cardiovascular parameters
  • Labyrinthitis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Young GroupWhole Body VibrationHealthy young of both sexes between the ages of 18 and 30 years will perform a whole body vibration session
Elderly GroupWhole Body VibrationHealthy elderly of both sexes between the ages of 60 and 80 years will perform a whole body vibration session
Primary Outcome Measures
NameTimeMethod
Autonomic FunctionChange from Baseline Heart rate variability at 5, 10, 15, 20 and 35 minutes

Heart rate variability will be assessed from 3-channel holter

Secondary Outcome Measures
NameTimeMethod
Parasympathetic modulationChange from Baseline Parasympathetic modulation at 5, 10, 15, 20 and 35 minutes

Parasympathetic modulation will be assessed from 3-channel holter

Heart RateChange from Baseline Heart Rate at 5, 10, 15, 20 and 35 minutes

Non-invasive measures will be assessed from 3-channel holter

Peripheral oxygen saturationChange from Baseline Peripheral oxygen saturation at 5, 10, 15, 20 and 35 minutes

Non-invasive measures will be assessed from pulse oximeter

Blood pressureChange from Baseline Blood pressure at 5, 10, 15, 20 and 35 minutes

Non-invasive measures of brachial blood pressure

Sympathovagal BalanceChange from Baseline Sympathovagal balance at 5, 10, 15, 20 and 35 minutes

Sympathovagal Balance will be assessed from 3-channel holter

Adverse effectsChange from Baseline at 20 minutes

Adverse effects reported by volunteers

Sympathetic modulationChange from Baseline Sympathetic modulation at 5, 10, 15, 20 and 35 minutes

Sympathetic modulation will be assessed from 3-channel holter

Trial Locations

Locations (1)

Federal University of Pernambuco

🇧🇷

Recife, Pernambuco, Brazil

© Copyright 2025. All Rights Reserved by MedPath